|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0006142,
umls-concept:C0014939,
umls-concept:C0039286,
umls-concept:C0055987,
umls-concept:C0205420,
umls-concept:C0232970,
umls-concept:C0746319,
umls-concept:C1516213,
umls-concept:C1519429,
umls-concept:C1522673,
umls-concept:C2603343
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
1994-11-4
|
|
pubmed:abstractText |
To compare chemohormonal therapy, chemotherapy alone, and hormonal therapy alone in postmenopausal patients with estrogen receptor (ER)-positive operable breast cancer and positive axillary nodes with respect to survival and disease-free survival (DFS).
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
12
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2078-85
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:7931477-Adult,
pubmed-meshheading:7931477-Aged,
pubmed-meshheading:7931477-Aged, 80 and over,
pubmed-meshheading:7931477-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:7931477-Breast Neoplasms,
pubmed-meshheading:7931477-Chemotherapy, Adjuvant,
pubmed-meshheading:7931477-Cyclophosphamide,
pubmed-meshheading:7931477-Disease-Free Survival,
pubmed-meshheading:7931477-Female,
pubmed-meshheading:7931477-Fluorouracil,
pubmed-meshheading:7931477-Follow-Up Studies,
pubmed-meshheading:7931477-Humans,
pubmed-meshheading:7931477-Lymph Nodes,
pubmed-meshheading:7931477-Lymphatic Metastasis,
pubmed-meshheading:7931477-Methotrexate,
pubmed-meshheading:7931477-Middle Aged,
pubmed-meshheading:7931477-Postmenopause,
pubmed-meshheading:7931477-Prednisone,
pubmed-meshheading:7931477-Proportional Hazards Models,
pubmed-meshheading:7931477-Receptors, Estrogen,
pubmed-meshheading:7931477-Tamoxifen,
pubmed-meshheading:7931477-United States,
pubmed-meshheading:7931477-Vincristine
|
|
pubmed:year |
1994
|
|
pubmed:articleTitle |
Adjuvant CMFVP versus tamoxifen versus concurrent CMFVP and tamoxifen for postmenopausal, node-positive, and estrogen receptor-positive breast cancer patients: a Southwest Oncology Group study.
|
|
pubmed:affiliation |
Puget Sound Oncology Consortium, Seattle, WA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Research Support, U.S. Gov't, P.H.S.,
Randomized Controlled Trial,
Multicenter Study
|
